Oligopeptide-binding protein A is a potential target for combating Salmonella infection
15 affiliations
- 1Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN)
- 2Biomanufacturing Process Research Center, National Institute of Advanced and Industrial Science and Technology (AIST)
- 3The Research Foundation for Microbial Diseases of The University of Osaka
- 4BIKEN-RIMD NGS Laboratory, Research Institute for Microbial Diseases, The University of Osaka
- 5Laboratory of Proteomics for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition (NIBN)
- 6Graduate School of Pharmaceutical Sciences, The University of Osaka
- 7Laboratory of Functional Anatomy, Department of Life Sciences, School of Agriculture, Meiji University
- 8Graduate School of Veterinary Science, Osaka Metropolitan University
- 9Graduate School of Medicine, The University of Osaka
- 10Graduate School of Dentistry, The University of Osaka
- 11Graduate School of Science, The University of Osaka
- 12International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo
- 13Department of Microbiology and Immunology, Kobe University Graduate School of Medicine
- 14Graduate School of Biomedical and Health Sciences, Hiroshima University
- 15Research Organization for Nano and Life Innovation, Waseda University
Abstract
Introduction: Salmonella infection remains a pervasive diarrheal illness, particularly affecting populations in developing countries. The lack of an effective vaccine against non-typhoidal Salmonella is attributable to antigenic diversity among serotypes, incomplete understanding of protective immune mechanisms, and the difficulty in identifying conserved antigens capable of eliciting broad cross-protective immunity.
Methods: To identify conserved Salmonella antigens, we established a Salmonella -specific monoclonal antibody library using heat-killed bacteria. Candidate antigens recognized by monoclonal antibodies were characterized, and their functional relevance was evaluated through analyses of bacterial growth, respiratory activity, and protective effects in a murine Salmonella infection model.
Results: We identified L2-1H11, a monoclonal antibody that recognizes OppA, a conserved antigen present across multiple Salmonella serotypes. L2-1H11 was associated with suppression of bacterial growth and respiratory activity and attenuated enteritis pathology in Salmonella -infected mice.
Conclusion: These findings identify OppA as a conserved Salmonella antigen and suggest that it may represent a promising target for the development of subcutaneous and oral vaccines against Salmonella .
Related
- Functional decoding reveals a hidden regulatory layer of the Salmonella transcriptome during infection
- Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice
- Probiotic Lactobacillus acidophilus provides an adjuvant effect to an orally administered chitosan nanoparticle-based Salmonella subunit vaccine in broilers against Salmonella Enteritidis infection
- Comparative analysis of immunomodulatory effects of Artemisinin and Parthenolide on activation of immune cells and their roles in Salmonella Typhimurium infection
- Schistosoma-Salmonella co-infection in Africa: Epidemiology, biological mechanisms, and antimicrobial resistance: A systematic review and meta analysis
BibTeX
@article{yoshii2026oligopeptidebinding,
title = {{Oligopeptide-binding protein A is a potential target for combating Salmonella infection}},
author = {Ken Yoshii and Koichiro Suzuki and Jun Adachi and Zhenyu Piao and Eri Node and Zilai Liu and Takahiro Nagatake and Koji Hosomi and Jun Kunisawa},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1943609},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1943609/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Oligopeptide-binding protein A is a potential target for combating Salmonella infection
AU - Ken Yoshii
AU - Koichiro Suzuki
AU - Jun Adachi
AU - Zhenyu Piao
AU - Eri Node
AU - Zilai Liu
AU - Takahiro Nagatake
AU - Koji Hosomi
AU - Jun Kunisawa
PY - 2026
DA - 2026/10/09
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1943609
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1943609/full
AB - Introduction: Salmonella infection remains a pervasive diarrheal illness, particularly affecting populations in developing countries. The lack of an effective vaccine against non-typhoidal Salmonella is attributable to antigenic diversity among serotypes, incomplete understanding of protective immune mechanisms, and the difficulty in identifying conserved antigens capable of eliciting broad cross-protective immunity. Methods: To identify conserved Salmonella antigens, we established a Salmonella -specific monoclonal antibody library using heat-killed bacteria. Candidate antigens recognized by monoclonal antibodies were characterized, and their functional relevance was evaluated through analyses of bacterial growth, respiratory activity, and protective effects in a murine Salmonella infection model. Results: We identified L2-1H11, a monoclonal antibody that recognizes OppA, a conserved antigen present across multiple Salmonella serotypes. L2-1H11 was associated with suppression of bacterial growth and respiratory activity and attenuated enteritis pathology in Salmonella -infected mice. Conclusion: These findings identify OppA as a conserved Salmonella antigen and suggest that it may represent a promising target for the development of subcutaneous and oral vaccines against Salmonella .
SN - 1664-3224
ER -